Literature DB >> 19819378

Retraction--Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.

.   

Abstract

Entities:  

Year:  2009        PMID： 19819378     DOI： 10.1016/S0140-6736(09)61768-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Should two-drug initial therapy for hypertension be recommended for all patients?

Authors:  Jennifer B Cowart; Addison A Taylor
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

Review 2.  Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease.

Authors:  Raimund H Pichler; Ian H de Boer
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

Review 3.  Chronic kidney disease and albuminuria in arterial hypertension.

Authors:  Giovanna Leoncini; Francesca Viazzi; Roberto Pontremoli
Journal:  Curr Hypertens Rep       Date:  2010-10       Impact factor: 5.369

Review 4.  Renal failure (chronic).

Authors:  Catherine Clase
Journal:  BMJ Clin Evid       Date:  2011-05-25

Review 5.  Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes.

Authors:  Kirk N Campbell; Leopoldo Raij; Peter Mundel
Journal:  Curr Diabetes Rev       Date:  2011-01

6.  Blood pressure and diabetic nephropathy.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2010-03       Impact factor: 19.112

7.  The role of renin angiotensin system inhibition in kidney repair.

Authors:  Irene M van der Meer; Paolo Cravedi; Giuseppe Remuzzi
Journal:  Fibrogenesis Tissue Repair       Date:  2010-05-04

8.  Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.

Authors:  Maartje C J Slagman; Femke Waanders; Marc H Hemmelder; Arend-Jan Woittiez; Wilbert M T Janssen; Hiddo J Lambers Heerspink; Gerjan Navis; Gozewijn D Laverman
Journal:  BMJ       Date:  2011-07-26

Review 9.  Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials.

Authors:  Harikrishna Makani; Sripal Bangalore; Kavit A Desouza; Arpit Shah; Franz H Messerli
Journal:  BMJ       Date:  2013-01-28

Review 10.  Antihypertensive treatment and renal protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system.

Authors:  Francesca Viazzi; Giovanna Leoncini; Roberto Pontremoli
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.